Premium
Development of Federally Mandated Risk Evaluation and Mitigation Strategies ( REMS ) for Transmucosal Immediate‐Release Fentanyl Products
Author(s) -
Pergolizzi Joseph V.,
Gharibo Christopher G.,
Gudin Jeffrey A.,
Nalamachu Srinivas R.
Publication year - 2013
Publication title -
pain practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 58
eISSN - 1533-2500
pISSN - 1530-7085
DOI - 10.1111/papr.12040
Subject(s) - medicine , oxycodone , medical prescription , accidental , drug , opioid , medical emergency , fentanyl , opioid overdose , adverse effect , addiction , food and drug administration , intensive care medicine , pharmacology , psychiatry , (+) naloxone , physics , receptor , acoustics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom